The Effect of Pipeline Success on Clinical Trial Supplies to be Presented by Catalent at SCOPE Summit

Tuesday, February 12, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Catalent Pharma Solutions, a global leader in clinical supply services, today announced that Eva Allen, Senior Clinical Supplies Manager, will present at the upcoming 10th Annual SCOPE Summit for Clinical Ops Executives at the Hyatt Regency Orlando Hotel, Orlando, Florida, on Feb. 18-21, 2019.

SOMERSET, N.J., Feb. 12, 2019 /PRNewswire-PRWeb/ -- Catalent Pharma Solutions, a global leader in clinical supply services,

today announced that Eva Allen, Senior Clinical Supplies Manager, will present at the upcoming 10th Annual SCOPE Summit for Clinical Ops Executives at the Hyatt Regency Orlando Hotel, Orlando, Florida, on Feb. 18-21, 2019.

In her presentation, "Turning Up the Heat: The Effect of Pipeline Success on Clinical Supplies" on Tuesday, Feb. 19 at 3:40 p.m., Ms. Allen will discuss the ways in which clinical supply strategy and execution change as sponsors progress into later phase trials. Her presentation will explore the aspects of clinical supply that sponsors find most challenging, and the primary concerns associated with outsourcing clinical supplies. She will also discuss clinical supply considerations for studies conducted outside of North America.

In her role at Catalent, Ms. Allen is responsible for end-to-end clinical supply strategy, forecasting, and support, including interactive response technology (IRT) set up and inventory management. She has 18 years' experience in the pharmaceutical industry, focusing on commercial and clinical manufacturing supplies management. Ms. Allen holds a bachelor's degree in industrial distribution and logistics from East Carolina University.

For more information visit this page.

To arrange a meeting with Ms. Allen at the conference, contact Ed Dutton at NEPR – edward@nepr.eu

About Catalent Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across five continents, and in fiscal 2018 generated approximately $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied.™

 

SOURCE Catalent Pharma Solutions



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store